Aptose Biosciences Overview
- Year Founded
-
1986
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
M&A
- Financing Rounds
-
22
- Investments
-
1
Aptose Biosciences General Information
Description
Aptose Biosciences Inc is a clinical-stage biotechnology company. Its compound tuspetinib is a convenient once daily oral agent that potently targets SYK, mutated and wild-type forms of FLT3, mutated KIT, JAK1/2, and RSK2 kinases, while avoiding many typical toxicity concerns observed with other agents. The ongoing TUSCANY triplet Phase 1/2 study is designed to test various doses and schedules of TUS in combination with standard dosing of azacitidine and venetoclax in newly diagnosed patients with AML who are ineligible to receive induction chemotherapy. The group has reported data from the first three dose cohorts that demonstrated safety, CRs, and minimal residual disease (MRD) negativity across patients with diverse mutations.
Contact Information
Website
www.aptose.comCorporate Office
- 66 Wellington Street West
- Suite 5300, TD Bank Tower, Box 48
- Toronto, Ontario M5K 1E6
- Canada
Corporate Office
- 66 Wellington Street West
- Suite 5300, TD Bank Tower, Box 48
- Toronto, Ontario M5K 1E6
- Canada
Aptose Biosciences Timeline
Aptose Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aptose Biosciences Comparisons
Industry
Financing
Details
Aptose Biosciences Competitors (56)
One of Aptose Biosciences’s 56 competitors is Rein Therapeutics, a Formerly VC-backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| XBiotech | Corporation | Austin, TX | ||||
| Oncorus | Formerly VC-backed | Andover, MA |
Aptose Biosciences Patents
Aptose Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4630122-A1 | Methods for treating patients with hematologic malignancies | Pending | 10-Dec-2022 | ||
| US-20260199335-A1 | Methods for treating patients with hematologic malignancies | Pending | 10-Dec-2022 | ||
| WO-2024124199-A1 | Methods for treating patients with hematologic malignancies | Inactive | 10-Dec-2022 | ||
| WO-2024124199-A9 | Methods for treating patients with hematologic malignancies | Inactive | 10-Dec-2022 | ||
| WO-2021247717-A1 | 2-indolyl imidazo [4,5-d] phenanthroline polymorphs and compositions regarding the same | Inactive | 02-Jun-2020 | C07D471/14 |
Aptose Biosciences Signals
Aptose Biosciences Investments (1)
Aptose Biosciences’s most recent deal was a Corporate Asset Purchase with CrystalGenomics (China rights to CG-806) for . The deal was made on 14-Jun-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CrystalGenomics (China rights to CG-806) | 14-Jun-2018 | Corporate Asset Purchase | Buildings and Property |
Aptose Biosciences FAQs
-
When was Aptose Biosciences founded?
Aptose Biosciences was founded in 1986.
-
Where is Aptose Biosciences headquartered?
Aptose Biosciences is headquartered in Toronto, Canada.
-
What is the size of Aptose Biosciences?
Aptose Biosciences has 14 total employees.
-
What industry is Aptose Biosciences in?
Aptose Biosciences’s primary industry is Drug Discovery.
-
Is Aptose Biosciences a private or public company?
Aptose Biosciences is a Private company.
-
What is the current valuation of Aptose Biosciences?
The current valuation of Aptose Biosciences is .
-
What is Aptose Biosciences’s current revenue?
The current revenue for Aptose Biosciences is .
-
How much funding has Aptose Biosciences raised over time?
Aptose Biosciences has raised $236M.
-
Who are Aptose Biosciences’s competitors?
Rein Therapeutics, Inovio Pharmaceuticals, Kite Pharma, XBiotech, and Oncorus are some of the 56 competitors of Aptose Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process